Cholesterol drug could be financial boon for Merck
Cholesterol drug could be financial boon for Merck
A new drug being developed by Merck & Co. could follow Lipitor as the next mega-blockbuster cholesterol drug, if it clears several important hurdles.
Read more on AP via Yahoo! Finance
